The week in health tech, explained in plain English.Get the free newsletter →
October 24, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Health IT

Boston Scientific Restores Cardiac Remote Monitoring After Hack

Boston Scientific announced Sept. 8 that it has restored the ability to activate remote monitoring for cardiac devices, closing out a disruption that began with an Aug. 25 cybersecurity incident, according to Becker's Hospital Review.

The network disruption blocked new remote monitoring activations and pairing for cardiac device implant communicators and insertable cardiac monitors. In practice, that meant clinicians could not enroll newly implanted patients into remote monitoring during the roughly two-week window. Boston Scientific said healthcare professionals can now resume activation and pairing for those devices.

The episode is a reminder that connected medical devices carry the same cyber exposure as any networked system, and that outages can interrupt clinical workflows even when the implants themselves keep working. As remote monitoring becomes standard for pacemakers, defibrillators, and cardiac monitors, hospitals and device makers face growing pressure to build redundancy so that a single vendor's network problem does not stall patient enrollment or care.

More in Health IT

Health IT

Epic Opens Its Platform Wider to AI and Outside Developers

Epic used its Open@Epic developer conference to open its platform wider to outside AI and apps while reminding developers that the resulting traffic runs on hospitals' infrastructure.

Why it matters: As the dominant EHR vendor, Epic's decision to open its platform shapes how and where clinical AI gets deployed across most U.S. hospitals.

Health IT

After AI Go-Live, Who Owns Monitoring? Often No One

Health systems scrutinize AI before go-live, but post-deployment monitoring responsibilities often remain undefined, leaving no clear owner when models drift.

Why it matters: Unmonitored AI models can quietly degrade in clinical settings, putting patient safety at risk when no one is accountable for watching performance after launch.